Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001129928-25-000095
Filing Date
2025-12-10
Accepted
2025-12-09 18:02:43
Documents
2
Period of Report
2025-12-09

Document Format Files

Seq Description Document Type Size
1 6-K form6krescheduledmeeting.htm 6-K 17847
2 EX-99.1 rescheduledmeeting.htm EX-99.1 20360
  Complete submission text file 0001129928-25-000095.txt   39260
Mailing Address 804, 322 - 11 AVENUE SW CALGARY Alberta, Canada
Business Address 804, 322 - 11 AVENUE SW CALGARY Alberta, Canada 4036707377
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38512 | Film No.: 251560218
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)